Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
NPJ Precision Oncology|February 16, 2024
EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancersMarco Tagliamento, Marie Morfouace, Charalambos Loizides, et al.
European Journal of Clinical Investigation|August 14, 2021
Serum levels of VCAM-1 are associated with survival in patients treated with nivolumab for NSCLCFederico Carbone, Stefano Ministrini, Aldo Bonaventura, et al.
JCO Global Oncology|February 2, 2021
Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in OncologyConcetta Elisa Onesti, Marco Tagliamento, Giuseppe Curigliano, et al.
Clinical & Experimental Metastasis|August 4, 2019
Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancerFederico Carbone, Francesco Grossi, Aldo Bonaventura, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 2019
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot studyAldo Bonaventura, Francesco Grossi, Federico Carbone, et al.
Critical Reviews in Oncology/Hematology|February 22, 2022
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesotheliomaMarco Tagliamento, Paolo Bironzo, Hubert Curcio, et al.
Translational Lung Cancer Research|August 13, 2025
Upfront osimertinib and as sequential therapy in patients with EGFR-mutant non-small cell lung cancer (NSCLC): benefit across patients groups in a real-world retrospective cohort-the smile studyEdouard Auclin, Pauline Du Rusquec, Victor Albarran-Artahona, et al.
Cancer Treatment and Research Communications|September 1, 2024
Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patientsFrancesca Parisi, Giuseppa De Luca, Manuela Mosconi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2026
Role of ctDNA Tumor Fraction in Selecting Immunotherapy Based Regimens in Advanced Non-small Cell Lung CancerFilippo G Dall'Olio, Wael Zrafi, Damien Vasseur, et al.
NPJ Precision Oncology|February 26, 2024
Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patientsDamien Vasseur, Ahmadreza Arbab, Fabiola Giudici, et al.
Pageof 9